Cutler Group LP Bei Gene, Ltd. Call Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Jan 18, 2022	BUY	$248.56 - $389.34 $24,856 - $38,934	100 New	100 $1,000
Q2 2021 Jul 19, 2021	SELL	$292.75 - $367.01 $322,025 - $403,711	-1,100 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$221.31 - $316.61 $199,179 - $284,949	-900 Reduced 45.0%	1,100 $74,000
Q3 2020 Oct 27, 2020	SELL	$189.18 - $286.44 $681,048 - $1.03 Million	-3,600 Reduced 64.29%	2,000 $224,000
Q2 2020 Jul 22, 2020	BUY	$123.9 - $195.41 $557,550 - $879,345	4,500 Added 409.09%	5,600 $88,000
Q4 2019 Feb 06, 2020	BUY	$115.78 - $208.34 $92,624 - $166,672	800 Added 266.67%	1,100 $31,000
Q3 2019 Oct 28, 2019	SELL	$120.61 - $148.29 $337,708 - $415,212	-2,800 Reduced 90.32%	300 $1,000
Q2 2019 Aug 09, 2019	BUY	$113.99 - $146.86 $125,389 - $161,546	1,100 Added 55.0%	3,100 $16,000
Q1 2019 May 10, 2019	BUY	$122.82 - $151.83 $122,820 - $151,830	1,000 Added 100.0%	2,000 $7,000
Q4 2018 Feb 05, 2019	SELL	$107.01 - $175.15 $802,575 - $1.31 Million	-7,500 Reduced 88.24%	1,000 $11,000
Q3 2018 Nov 07, 2018	BUY	$152.62 - $189.66 $442,598 - $550,014	2,900 Added 51.79%	8,500 $58,000
Q2 2018 Aug 10, 2018	BUY	$152.5 - $216.77 $15,250 - $21,677	100 Added 1.82%	5,600 $5,000
Q1 2018 May 11, 2018	BUY	$97.41 - $177.22 $311,712 - $567,104	3,200 Added 139.13%	5,500 $145,000
Q4 2017 Jan 17, 2018	BUY	$79.6 - $114.73 $103,479 - $149,149	1,300 Added 130.0%	2,300 $28,000
Q3 2017 Oct 17, 2017	BUY	$66.19 - $103.46 $66,190 - $103,460	1,000	1,000 $20,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.